Purpose: Opioid medications are necessary in the treatment of critically ill infants; however. prolonged use may lead to withdrawal syndrome. The purpose of this study was to assess feasibility of delivering an acupressure protocol for the treatment of iatrogenic withdrawal in a pediatric cardiac intensive care unit as well as impact and acceptance of acupressure as an adjunct treatment.
Design: Randomized pilot feasibility trial.
Methods: Acupressure stickers were applied and rotated to one ear every 1-3 days until withdrawal symptoms improved.
Results: There were no serious adverse events, with only one reported incident of skin irritation. Recruiting benchmarks were exceeded. Weaning phases were significantly shorter in the acupressure group (medians 6.0 vs 22.0 respectively, p = .025, d = 0.90) and the control group used skin-to-skin contact as a comfort measure significantly more than the acupressure group (42.9% vs 6.3%, p = .18). Acupressure was accepted by parents, with an overall 96.2% rating their experience as positive, as measured by the Parent Client Satisfaction Questionnaire. The majority of health care providers (n = 19) were supportive, with 71.9% agreeing or completely agreeing acupressure is an acceptable adjunct for the treatment of withdrawal symptoms; 26.8% were neutral, as measured by the Acceptability of Intervention Measure, Intervention Appropriateness Measure, and Feasibility of Intervention Measure.
Conclusions: Acupressure was found to be safe, feasible, and accepted by health care providers in a pediatric cardiac intensive care setting.
Clinical implications: These findings support future research with larger sample sizes to improve clinical treatment of infants physically dependent on sedative medications.
Keywords: Auricular acupressure; Iatrogenic withdrawal syndrome; Opioid taper; Opioid withdrawal.
Copyright © 2024 The Authors. Published by Elsevier Inc. All rights reserved.